Storia in 6 fonti

Less stress, addiction, brain fog: Ozempic, GLP-1 drugs may be impacting patients' brain, neural networks

GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress | World News

Raccontata dainfobae.comsciencealert.comindependent.co.ukgizmodo.comhindustantimes.comsciencedaily.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

hindustantimes.comStai leggendo1 mesi fa

Less stress, addiction, brain fog: Ozempic, GLP-1 drugs may be impacting patients' brain, neural networks

GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress | World News

originale

independent.co.uk1 mesi fa

Another effect of weight loss drugs could be changing the brain, research suggests

University of Colorado Anschutz found GLP-1 drugs boost brain connectivity within months, reducing addictive behaviors and improving attention. If confirmed, GLP-1s shift from metabolic to CNS drugs, reshaping pharma pipelines and enterprise health budgets.

Leggi questa versione → originale

gizmodo.com1 mesi fa

Can Ozempic Treat Alcoholism? Here's What You Should Know

A first Lancet RCT (26 weeks, n=100) found semaglutide reduced alcohol consumption and heavy drinking days vs placebo. The shared dopamine mechanism implies GLP-1s could address multiple addictions, reshaping Novo Nordisk's pipeline beyond obesity.

Leggi questa versione → originale

sciencedaily.com1 mesi fa

Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

GLP-1 drugs reduce substance use disorder risk 14-25% and overdose mortality 50%, per 606k-veteran study validating broader therapeutic applications in addiction. Existing GLP-1 drugs may unlock addiction treatment via shared craving biology, shortcutting drug development cycles without new compound discovery.

Leggi questa versione → originale

sciencealert.com1 mesi fa

Weight Loss on GLP-1 Drugs Linked to Lower Risk of Disease, Study Finds

Does losing weight by taking GLP-1 drugs such as Ozempic and Wegovy actually improve your risk of other diseases associated with obesity? New research led by scientists at the University of Liverpool in the UK, and…

Leggi questa versione → originale

infobae.com1 mesi fa

Ozempic podría modificar la función cerebral, según nuevos estudios

Científicos han detectado cambios inesperados en la conectividad cerebral de pacientes tratados con Ozempic y otros medicamentos GLP-1, lo que abre nuevas preguntas sobre el alcance de estos fármacos más allá del…

Leggi questa versione → originale

Timeline cronologica

1. giovedì 28 maggio 2026·infobae.com
   

   Ozempic podría modificar la función cerebral, según nuevos estudios

   Científicos han detectado cambios inesperados en la conectividad cerebral de pacientes tratados con Ozempic y otros medicamentos GLP-1, lo que abre nuevas preguntas sobre el…

2. giovedì 28 maggio 2026·sciencealert.com
   

   Weight Loss on GLP-1 Drugs Linked to Lower Risk of Disease, Study Finds

   Does losing weight by taking GLP-1 drugs such as Ozempic and Wegovy actually improve your risk of other diseases associated with obesity? New research led by scientists at the…

3. giovedì 28 maggio 2026·independent.co.uk
   

   Another effect of weight loss drugs could be changing the brain, research suggests

   Scientists are looking to see how GLP-1 drugs may impact the brain and reshape people’s nervous systems

4. venerdì 29 maggio 2026·gizmodo.com
   

   Can Ozempic Treat Alcoholism? Here's What You Should Know

   A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.

5. sabato 30 maggio 2026·hindustantimes.com
   

   Less stress, addiction, brain fog: Ozempic, GLP-1 drugs may be impacting patients' brain, neural networks

   GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress | World News

6. lunedì 1 giugno 2026·sciencedaily.com
   

   Scientists discover why ozempic may not work for some people

   Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these…

7. lunedì 1 giugno 2026·sciencedaily.com
   

   Ozempic and Wegovy linked to surprising drop in violent behavior

   A Rutgers study suggests GLP-1 drugs such as Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior. The surprising finding hints that these…

8. lunedì 1 giugno 2026·sciencedaily.com
   

   Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

   A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also…

9. lunedì 1 giugno 2026·sciencedaily.com
   

   People taking GLP-1 weight loss drugs like Ozempic started moving less

   People taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound may be losing pounds, but they could also be moving less. Researchers analyzing Fitbit data…